Raymond James & Associates’s Cronos Group CRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-97,900
Closed -$6K 3980
2022
Q2
$6K Hold
97,900
﹤0.01% 3959
2022
Q1
$68K Buy
97,900
+15,400
+19% +$56.1K ﹤0.01% 3882
2021
Q4
$72K Buy
82,500
+2,700
+3% +$13.5K ﹤0.01% 3913
2021
Q3
$146K Sell
79,800
-24,100
-23% -$164K ﹤0.01% 3747
2021
Q2
$352K Sell
103,900
-3,100
-3% -$25.6K ﹤0.01% 3322
2021
Q1
$400K Buy
107,000
+600
+0.6% +$6.35K ﹤0.01% 3171
2020
Q4
$278K Buy
+106,400
New +$732K ﹤0.01% 3163

Other funds holding CRON

Raymond James & Associates's CRON Position: Q3 2024 in Review

Raymond James & Associates reduced its Cronos Group (CRON) stake by 0.03% in Q3 2024, selling an estimated $23 and leaving 28,633 shares worth $62.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3830.

Raymond James & Associates first reported a position in CRON in Q1 2019 and has held it in 23 quarters since. The position peaked at $856K in Q2 2021. 178 funds tracked by Wall St. Rank hold CRON as of Q3 2024.

  • Raymond James & Associates held 28,633 shares of Cronos Group worth $62.7K as of Q3 2024.
  • Raymond James & Associates sold 10 Cronos Group shares in Q3 2024, an estimated $23.
  • Cronos Group made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3830 holding.
  • Raymond James & Associates first reported a position in Cronos Group in Q1 2019 and has held it in 23 quarters since.
  • Raymond James & Associates's Cronos Group position peaked at $856K in Q2 2021.
  • 178 funds tracked by Wall St. Rank held Cronos Group as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.